Skip to main content
. 2018 Nov 23;9(92):36413–36429. doi: 10.18632/oncotarget.26326

Figure 5. SP-2509 DR-washout cells lose their enhanced sensitivity to HDAC inhibitors.

Figure 5

(A) Parental and SP-2509 DR-washout A673 cells were treated with the indicated agents for 72 hrs. Cell viability was assessed through CellTiter Glo analysis. Data represents mean viability ± SEM from three independent experiments. (B) Mean IC50 ± SEM and 95% confidence interval for each agent.